Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • TPG-Backed Manipal...

    TPG-Backed Manipal Revises Bid for Fortis

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-05-07T11:44:21+05:30  |  Updated On 7 May 2018 11:44 AM IST
    TPG-Backed Manipal Revises Bid for Fortis

    (Bloomberg Report)- Fortis Healthcare Ltd. received a revised takeover offer from its first suitor, an Indian company backed by private equity firm TPG, ahead of a board meeting to decide a winner in the bidding war for the country’s second-largest hospital chain.



    Manipal Health Enterprises Pvt. has proposed merging with Fortis in a deal that will value the latter at 83.58 billion rupees ($1.3 billion), translating into 160 rupees a share, it said Sunday in a letter to Fortis board. While Manipal has proposed a rights issue of the merged entity, it has offered to subscribe for a preferential allotment of Fortis shares at the same price per share, totalling 21 billion rupees, for short-term liquidity needs, according to the letter.


    With the Fortis board set to meet May 10 to decide on which of the proposals to refer to shareholders for a vote, the race for the hospital chain is getting closer to the finish line. Still, the stockholders will have to decide on a motion to remove the majority of the board members before voting on the selected bid. An extra-ordinary meeting is scheduled for May 22.


    The takeover battle for Fortis was kicked off earlier this year when its founders lost control of their shareholding because of their mounting debts. India’s fraud office began investigating the company after Bloomberg News reported people with knowledge of the matter as saying the founders had taken millions of dollars out of the company without board permission.


    Intense Race

    Fortis has since drawn international bidders intent on securing a place in one of the most under-served health-care markets in the world. India has about half a hospital bed for every thousand people, according to the Organization for Economic Cooperation and Development, even as faster growth than many other large economies increases patients’ ability to pay for better health care.


    Manipal Health has offered to buy the stake held by private equity firms in SRL Ltd. at a price that values the Fortis unit at 36 billion rupees, subject to an agreement with the holders.


    Fortis has also drawn offers from IHH Healthcare Bhd., Asia’s most valuable hospital operator, KKR & Co.-backed Radiant Life Care Pvt., Chinese conglomerate Fosun International Ltd. and a joint bid from an alliance of two Indian business families. Fortis has appointed Arpwood Capital to advise it on the offers.


    The offers range from about 156 rupees per share from Fosun to IHH’s 175 rupees apiece. Each proposal also varies in structure. IHH has proposed making an immediate equity investment, and putting in more after completing due diligence. Fortis has said it will only examine binding bids, and Fosun’s is the only one with no binding elements.


    Meanwhile, Jupiter India Fund and East Bridge Capital Master Fund, which own a combined 12.04 percent of Fortis, have put forward a motion to remove four Fortis board members and replace them with three others. While the three were inducted into the Fortis board, the four they sought to remove remain.


    Bloomberg Report b By Ari Altstedter and Vrishti Beniwal
    bidbiddingChinese conglomerate Fosun International LtdEast Bridge Capital Master FundFortis boardFortis Healthcarehealth careIHH HealthcareIndiainvestigatingJupiter India FundManipal Health Enterprises PvtOrganization for Economic Cooperation and DevelopmentRadiant Life Care PvtshareholdersTPG
    Source : Blooomberg

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok